Cipla’s manufacturing facility in Goa gets VAI classification EP News Bureau Oct 31, 2024 The US FDA conducted a cGMP inspection between June 10-21, 2024
MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down EP News Bureau Sep 4, 2024 Cipla announces appointment of Kamil Hamied as Non-Executive Director
Cannes Lions 2024 showcase highlights key trends shaping future pharma marketing EP News Bureau Sep 2, 2024 The showcase hosted by The Work from LIONS, in collaboration with Medulla Communications, analysed the most impactful campaigns…
Orchid Pharma, Cipla to launch antibiotic Cefepime-Enmetazobactam in India EP News Bureau Jun 28, 2024 This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…
Cipla signs agreement with Takeda to commercialise Vonoprazan EP News Bureau Jun 26, 2024 This deal is meant to commercialise the drug in India under Cipla’s own trademark brands
Cipla gains USFDA approval for the generic version of Somatuline Depot (Lanreotide) injection EP News Bureau May 22, 2024 The new generic version to treat patients with GEP-NETs
Sanofi signs distribution pact with Cipla for CNS portfolio in India EP News Bureau Mar 27, 2024 Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium
Cipla receives USFDA approval for plazomicin injection in India EP News Bureau Feb 27, 2024 Plazomicin is a new Intravenous (IV) aminoglycoside indicated for the treatment of complicated urinary tract infections (cUTI)…
Cipla to further invest Rs 42 crore in GoApptiv EP News Bureau Dec 15, 2023 Strengthens investment in channels of the future to expand patient reach
NPPA slashes prices on 33 FDCs drugs EP News Bureau Nov 15, 2023 This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…